Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Oliver Contreras/Bloomberg via Getty Images

The Senate Homeland Security Committee and Senate Rules Committee will hold a joint hearing on Feb. 23 on the security failures that led to the breach of the Capitol by pro-Trump rioters on Jan. 6, the panels announced Tuesday.

Details: The committees have invited former U.S. Capitol Police chief Steven Sund, former House Sergeant at Arms Paul Irving, former Senate Sergeant at Arms Michael Stenger and D.C. Metropolitan Police Chief Robert Contee to testify. Sund, Irving and Stenger all resigned in the wake of the riots.

Why it matters: The hearing will likely be the tip of the iceberg when it comes to congressional investigations into the insurrection, which resulted in former President Trump's second impeachment and eventual acquittal in the Senate on Saturday.

  • House Speaker Nancy Pelosi on Monday said there will be an independent, 9/11-style commission set up to investigate the attack.
  • House Homeland Security Committee chairman Bennie Thompson (D-Miss.) sued Trump in federal court on Tuesday, accusing the former president and far-right groups of conspiring to incite a riot with the goal of preventing Congress from certifying the 2020 election.

Go deeper

Pelosi announces "9/11-type Commission" to probe Capitol attack

House Speaker Nancy Pelosi at the U.S. Capitol on Thursday. Photo: Samuel Corum/Getty Images

Speaker Nancy Pelosi (D-Calif.) said in a letter to House Democrats Monday an independent "9/11-type Commission" will be set up to investigate the Jan. 6 U.S. Capitol insurrection.

Why it matters: Calls for a bipartisan commission to investigate the deadly attack have grown in recent weeks, and escalated since former President Trump was acquitted Saturday of charges of high crimes and misdemeanors.

Updated Feb 16, 2021 - Politics & Policy

Richard Burr censured from North Carolina GOP after voting to convict Trump

Sen. Richard Burr in the Senate subway on Feb. 13. Photo: Samuel Corum/Getty Images

The North Carolina Republican Party announced Monday night that its members had voted unanimously to censure Sen. Richard Burr (R-N.C.) for finding former President Trump guilty of inciting the Jan. 6 Capitol siege.

The big picture: Most of the House Republicans who voted to impeach Trump in January have been censured.

14 hours ago - Health

FDA advisory panel recommends Pfizer boosters for those 65 and older

A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at the Key Biscayne Community Center on Aug. 24, 2021. Photo: Eva Marie Uzcategui/Bloomberg via Getty Images

A key Food and Drug Administration advisory panel on Friday overwhelmingly voted against recommending Pfizer vaccine booster shots for younger Americans, but unanimously recommended approving the third shots for individuals 65 and older, as well as those at high-risk of severe COVID-19.

Why it matters: While the votes are non-binding, and the FDA must still make a final decision, Friday's move pours cold water on the Biden administration's plan to begin administering boosters to most individuals who received the Pfizer vaccine later this month.